SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-19-001076
Filing Date
2019-02-21
Accepted
2019-02-21 09:15:14
Documents
2
Period of Report
2019-02-21

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_022119.htm 6-K 5536
2 PRESS RELEASE exh_991.htm EX-99.1 8716
  Complete submission text file 0001171843-19-001076.txt   15255
Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3
Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 450-686-4555
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-35776 | Film No.: 19620665
SIC: 2834 Pharmaceutical Preparations